ORGO
Organogenesis Holdings Inc - Ordinary Shares - Class A

3,196
Mkt Cap
$490.14M
Volume
131,774.00
52W High
$7.08
52W Low
$2.61
PE Ratio
-39.14
ORGO Fundamentals
Price
$3.74
Prev Close
$3.84
Open
$3.82
50D MA
$4.54
Beta
1.95
Avg. Volume
804,672.45
EPS (Annual)
$0.0065
P/B
1.91
Rev/Employee
$554,710.01
$450.93
Loading...
Loading...
News
all
press releases
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...
PR Newswire·13d ago
News Placeholder
More News
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...
PR Newswire·20d ago
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...
PR Newswire·27d ago
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...
PR Newswire·1mo ago
News Placeholder
Avista Healthcare Partners Announces Promotions
Avista Healthcare Partners Announces Promotions Avista Healthcare Partners Announces Promotions PR Newswire NEW YORK, Jan. 5, 2026 NEW YORK, Jan. 5, 2026 /PRNewswire/ -- Avista Healthcare Partners...
PR Newswire·1mo ago
News Placeholder
Organogenesis (NASDAQ:ORGO) Shares Down 5% - Here's What Happened
Organogenesis (NASDAQ:ORGO) Stock Price Down 5% - What's Next...
MarketBeat·1mo ago
News Placeholder
Organogenesis (NASDAQ:ORGO) Shares Gap Down - Time to Sell?
Organogenesis (NASDAQ:ORGO) Shares Gap Down - Should You Sell...
MarketBeat·2mo ago
News Placeholder
Assenagon Asset Management S.A. Has $20.49 Million Stock Position in Organogenesis $ORGO
Assenagon Asset Management S.A. lifted its holdings in Organogenesis (NASDAQ:ORGO - Free Report) by 69.9% during the third quarter, according to the company in its most recent Form 13F filing with...
MarketBeat·2mo ago
News Placeholder
Organogenesis (NASDAQ:ORGO) Shares Down 3.7% on Insider Selling
Organogenesis (NASDAQ:ORGO) Trading Down 3.7% on Insider Selling...
MarketBeat·2mo ago
News Placeholder
Insider Selling: Organogenesis (NASDAQ:ORGO) Director Sells 200,000 Shares of Stock
Organogenesis (NASDAQ:ORGO - Get Free Report) Director Glenn Nussdorf sold 200,000 shares of the business's stock in a transaction on Tuesday, December 16th. The stock was sold at an average price of...
MarketBeat·2mo ago
<
1
2
...
>

Latest ORGO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.